Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences

Erin Stashi1, Lei Wang, Shailaja K Mani

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030. berto@bcm.edu.

Insights

Steroid receptor coactivators (SRCs) regulate brain functions. SRC loss impacts motor coordination, anxiety, and pain sensitivity, with significant sex-based differences observed in SRC knockout mice.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Steroid receptor coactivators (SRCs) are crucial for gene transcription and are implicated in various diseases.
  • SRCs are highly expressed in the brain, suggesting vital roles in neurological functions.
  • Previous studies on SRC knockout mice are limited, necessitating further investigation into their specific brain functions.

Purpose of the Study:

  • To comprehensively assess the neurobehavioral phenotypes of SRC knockout mice.
  • To elucidate the roles of SRC1, SRC2, and SRC3 in anxiety, exploratory behavior, motor coordination, sensorimotor gating, and nociception.
  • To identify potential sex-specific effects of SRC loss on behavior.

Main Methods:

  • Utilized a neurobehavioral test battery on SRC1, SRC2, and SRC3 knockout mice (SRC(-/-)) and their wild-type (WT) littermates.
  • Evaluated anxiety-like behaviors, exploratory activity, motor coordination, sensorimotor gating (prepulse inhibition), and nociception.
  • Compared behavioral outcomes between male and female knockout mice and WT controls.

Main Results:

  • SRC1 deficiency impaired motor coordination and altered anxiety and nociception in a sex-dependent manner.
  • SRC2 deficiency affected anxiety and exploratory behavior in females and sensorimotor gating in males.
  • SRC3 deficiency led to sex-specific alterations in anxiety and exploratory behaviors, and reduced nocifensive responses in both sexes.

Conclusions:

  • Loss of SRCs results in distinct behavioral phenotypes, highlighting their importance in the brain.
  • The study reveals significant sex differences in the behavioral consequences of SRC deficiency.
  • These findings underscore the need to understand the general and sex-specific roles of SRCs in neural function and behavior.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...